Cancer News and Research

Latest Cancer News and Research

OXiGENE reports audited financial statements for fiscal year ended December 31, 2009

OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced that the audit report from its independent registered public accounting firm on its financial statements for the fiscal year ended December 31, 2009, included in the Company's Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 16, 2010, contains an explanatory paragraph regarding the Company's ability to continue as a going concern.

19 Mar 2010

NMA to discuss the impact of health care reform on health disparities

The National Medical Association, the nation's oldest and largest organization representing the interests of 30,000 African American physicians will hold a press conference to address health care reform legislation and its impact on health disparities.

19 Mar 2010

European CHMP issues positive opinion for Roche's Tarceva as maintenance therapy for NSCLC

Roche today announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for use of Tarceva(R) (erlotinib) as a maintenance therapy for people with advanced non-small cell lung cancer (NSCLC) and stable disease (cancer remains largely unchanged) after initial chemotherapy. The CHMP positive opinion clears the way for European Union approval and means that this group of patients may soon be able to benefit from earlier treatment with Tarceva.

19 Mar 2010

CHMP issues positive opinion recommending approval of Tarceva as monotherapy for NSCLC

OSI Pharmaceuticals, Inc. announced today that its international partner for Tarceva® (erlotinib), Roche, informed OSI that the European Committee for Medicinal Products for Human Use has issued a positive opinion recommending approval of Tarceva as monotherapy for maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer with stable disease following four cycles of standard platinum-based first-line chemotherapy.

19 Mar 2010

A.P. Pharma's NDA for APF530 in prevention of CINV: FDA issues Complete Response Letter

A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that it received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for APF530 in the prevention of both acute and delayed onset chemotherapy-induced nausea and vomiting.

19 Mar 2010

Research group unveils new computational strategy for GWAS

In the ongoing quest to identify the genetic factors involved in disease, scientists have increasingly turned to genome-wide association studies, or GWAS, which enable the scanning of up to a million genetic markers in thousands of individuals.

19 Mar 2010

Study reveals higher-than-normal blood levels of fructose in pancreatic cancer patients

Patients with pancreatic cancer have higher-than-normal blood levels of the refined sugar fructose, according to a recent study in the journal Pancreas, official journal of the American Pancreatic Association and the Japan Pancreas Society. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

19 Mar 2010

Hercules Technology Growth Capital commits over $52.0M in structured debt financing

Hercules Technology Growth Capital, Inc., the leading specialty finance company providing venture debt and equity to venture capital and private equity-backed technology and life science companies at all stages of development, today announced that it has committed over $52.0 million in structured debt financing to new and existing portfolio companies.

19 Mar 2010

AMAG Pharmaceuticals' abstract on ferumoxytol for CKD accepted for presentation at NKF 2010

AMAG Pharmaceuticals, Inc. today announced that one abstract has been accepted for presentation at the National Kidney Foundation 2010 Spring Clinical Meeting being held April 13-17, 2010 in Orlando, FL.

19 Mar 2010

Studies reveal increased polyp detection rates with TER during colonoscopy

Two new studies show an increase in polyp detection rates using the Third Eye Retroscope (TER), a retrograde viewing device, during colonoscopy. The first study found that TER added to standard colonoscopy detected 13.2 percent more polyps than colonoscopy alone, including 11 percent additional adenomas (precancerous polyps). A second study examined endoscopist experience using TER and its impact on polyp detection rates, concluding that polyp detection rates improved significantly with TER.

19 Mar 2010

Genes role in protecting intestinal tract from colitis may lead to potential targets for treatment

Scientists report a protein made by a gene already associated with a handful of human inflammatory immune diseases plays a pivotal role in protecting the intestinal tract from colitis.

19 Mar 2010

Study shows that steroids target hemangioma stem cells

Hemangiomas -- strawberry-like birthmarks that commonly develop in early infancy - are generally harmless, but up to 10 percent cause tissue distortion or destruction and sometimes obstruction of vision or breathing. Since the 1960s, problematic hemangiomas have been treated with corticosteroids such as dexamethasone or prednisone.

19 Mar 2010

Abstract about Phase I/II trial of ThermoDox in RCW accepted for presentation at ASCO 2010

Celsion Corporation today announced that an abstract about the Phase I/II trial of ThermoDox® in Recurrent Chest Wall Cancer (RCW) has been accepted for presentation at the American Society of Clinical Oncology 2010 Annual Meeting.

19 Mar 2010

Asian-language speakers actively use "quitlines", University of California study finds

Telephone counseling programs for smoking cessation, popularly known as "quitlines," are an increasingly common way for smokers to quit. Every state in the U.S. now has one. However, most of them provide counseling services in English and Spanish only. The only quitline so far to offer counseling in multiple Asian languages is the California Smokers' Helpline. Since 1993, the Helpline has been counseling smokers in Chinese (both Mandarin and Cantonese dialects), Korean and Vietnamese, in addition to English and Spanish.

19 Mar 2010

Technique of igniting nanoparticles with low-intensity laser may help destroy cancer cells from within

University of Florida engineering researchers have found they can ignite certain nanoparticles using a low-power laser, a development they say opens the door to a wave of new technologies in health care, computing and automotive design.

19 Mar 2010

Predominantly white, insured and sick patients frequently use ER

Frequent users of the emergency department are predominantly white, insured and at greater risk for hospitalization due to serious illness, despite public perceptions of them as abusers of the healthcare system with minor complaints and no health insurance. This is the consensus of a systematic review of two dozen published studies of so-called "frequent flyers" ("Frequent Users of Emergency Departments: The Myths, the Data, and the Policy Implications").

19 Mar 2010

QUANTEC review: Updated recommendations for safe irradiation of 16 organs

The Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) review has been published in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO) to update recommendations for the safe irradiation of 16 organs. For each organ, the relationship between dose/volume and clinical outcome is reviewed. These reviews replace initial recommendations published in 1991.

19 Mar 2010

Noscapine can be used as prophylactic treatment for prostate cancer: Study

New research has revealed a major breakthrough in the use of cough medicine ingredient noscapine as a prophylactic treatment for prostate cancer.

19 Mar 2010

Fraunhofer FIT to present IMIKRID and automated protein-level microscope system at HANNOVER MESSE

Proteins, the cellular building blocks, can be visualized and analyzed in great detail today. Here, Fraunhofer FIT presents a fully automated high-performance microscope. One of its diagnostic applications will be to study the complex interactions of proteins between cells. In tumor diagnostics our microscope allows to classify slightly different types of tumors more precisely and to fine-tune therapy accordingly.

19 Mar 2010

Global halt on Molybdenum-99 production: Discussion of implications

Discuss the severe Tc-99m shortage that will occur over a two-week period when cancer, heart and brain disease patients will experience delayed imaging tests because of a worldwide halt on Molybdenum-99 production

19 Mar 2010

Cancer News and Research

Latest Cancer News and Research

OXiGENE reports audited financial statements for fiscal year ended December 31, 2009

NMA to discuss the impact of health care reform on health disparities

European CHMP issues positive opinion for Roche's Tarceva as maintenance therapy for NSCLC

CHMP issues positive opinion recommending approval of Tarceva as monotherapy for NSCLC

A.P. Pharma's NDA for APF530 in prevention of CINV: FDA issues Complete Response Letter

Research group unveils new computational strategy for GWAS

Study reveals higher-than-normal blood levels of fructose in pancreatic cancer patients

Hercules Technology Growth Capital commits over $52.0M in structured debt financing

AMAG Pharmaceuticals' abstract on ferumoxytol for CKD accepted for presentation at NKF 2010

Studies reveal increased polyp detection rates with TER during colonoscopy

Genes role in protecting intestinal tract from colitis may lead to potential targets for treatment

Study shows that steroids target hemangioma stem cells

Abstract about Phase I/II trial of ThermoDox in RCW accepted for presentation at ASCO 2010

Asian-language speakers actively use "quitlines", University of California study finds

Technique of igniting nanoparticles with low-intensity laser may help destroy cancer cells from within

Predominantly white, insured and sick patients frequently use ER

QUANTEC review: Updated recommendations for safe irradiation of 16 organs

Noscapine can be used as prophylactic treatment for prostate cancer: Study

Fraunhofer FIT to present IMIKRID and automated protein-level microscope system at HANNOVER MESSE

Global halt on Molybdenum-99 production: Discussion of implications

Understanding the DNA Damage Response in Innate Immunity eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in